Distinguished in Primary Hyperoxaluria

Laure Collard

CHU Liège
Liege, WAL, BE 
Distinguished in Primary Hyperoxaluria
CHU Liège
Liege, WAL, BE 
OverviewLocationsClinical Research

Overview

Laure Collard practices in Liege, Belgium. Ms. Collard is rated as a Distinguished expert by MediFind in the treatment of Primary Hyperoxaluria. Her top areas of expertise are Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Nephrocalcinosis, Atypical Hemolytic Uremic Syndrome (aHUS), and Kidney Transplant.

Her clinical research consists of co-authoring 28 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 6 articles and participated in 2 clinical trials in the study of Primary Hyperoxaluria.

Gender
Female

Locations

CHU Liège
Liege, WAL, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III Double-blind, Randomised Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
A Phase III Double-blind, Randomised Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
Enrollment Status: Completed
Publish Date: December 10, 2021
Intervention Type: Other, Biological
Study Drug: Oxabact OC5 - Oxalobacter formigenes HC-1
Study Phase: Phase 3
An Open-label Single-arm Treatment Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact for Patients With Primary Hyperoxaluria Who Completed Study OC5-DB-02
An Open-label Single-arm Treatment Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact for Patients With Primary Hyperoxaluria Who Completed Study OC5-DB-02
Enrollment Status: Terminated
Publish Date: December 08, 2021
Intervention Type: Biological
Study Drug: Oxabact OC5 - Oxalobacter formigenes Strain HC-1
Study Phase: Phase 3
Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury
Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury
Enrollment Status: Terminated
Publish Date: April 15, 2021
Intervention Type: Procedure
View 2 Less Clinical Trials

28 Total Publications

Clinical and genetic characteristics of patients diagnosed with atypical hemolytic uremic syndrome (aHUS): epidemiological data from the Belgian cohort of the Global aHUS Registry.
Clinical and genetic characteristics of patients diagnosed with atypical hemolytic uremic syndrome (aHUS): epidemiological data from the Belgian cohort of the Global aHUS Registry.
Journal: Journal of nephrology
Published: February 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Collard's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile